Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS)-Reference-Cited by-同舟云学术

Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS)

Published:2021-01 Issue: Volume:138 Page:1-10
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Kawashima Hideyuki,Tomaniak Mariusz,Ono Masafumi,Wang Rutao,Hara Hironori,Gao Chao^ORCID,Takahashi Kuniaki,Sharif Faisal,Thury Attila,Suryapranata Harry,Walsh Simon,Cotton James,Carrie Didier^ORCID,Sabate Manel,Steinwender Clemens,Leibundgut Gregor^ORCID,Wykrzykowska Joanna,de Winter Robbert J.,Garg Scot^ORCID,Hamm Christian,Steg Philippe Gabriel,Jüni Peter,Vranckx Pascal,Valgimigli Marco,Windecker Stephan,Onuma Yoshinobu,Serruys Patrick W.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents;Mauri;N Engl J Med,2014

2. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

3. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Levine;J Am Coll Cardiol,2016

4. A critical appraisal of aspirin in secondary prevention: Is less more?;Gargiulo;Circulation,2016

5. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N Engl J Med,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trials using composite outcomes neglect the presence of competing risks: a methodological survey of cardiovascular studies;Journal of Clinical Epidemiology;2023-08

2. Ten-year all-cause mortality following staged percutaneous revascularization in patients with complex coronary artery disease;Cardiovascular Revascularization Medicine;2021-09

3. Aspirin-free antiplatelet regimens after PCI: insights from the GLOBAL LEADERS trial and beyond;European Heart Journal - Cardiovascular Pharmacotherapy;2021-04-30

4. P2Y12 Receptor Inhibitors in ACS Management with or without ST-segment Elevation;International Journal Of Pharmaceutical Research And Allied Sciences;2021